(Q47850259)

6 February 2018

title

Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations (English)

1 reference

6 February 2018

author name string

Kovacs SJ

1

1 reference

6 February 2018

Martin DE

2

1 reference

6 February 2018

Everitt DE

3

1 reference

6 February 2018

Patterson SD

4

1 reference

6 February 2018

Jorkasky DK

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

6 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

6 February 2018

volume

63

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

617-622

1 reference

6 February 2018

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

6β-Hydroxycortisol Excretion in Hypercortisolemic States*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Quantitative determination by HPLC of urinary 6?-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Effect of age and gender on the activity of human hepatic CYP3A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Noninvasive tests of CYP3A enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

The human hepatic cytochromes P450 involved in drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Urinary excretion of 6 beta-hydroxycortisol in states of altered thyroid function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Ratio of Urinary 6β-Hydroxycortisol to 17-Hydroxycorticosteroids in Patients with Liver Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Clinical Implications of Enzyme Induction and Enzyme Inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

Urinary 6 beta-hydroxy-cortisol in adrenocortical hyperfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990084-4

10.1016/S0009-9236(98)90084-4

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018